Market Cap 360.09M
Revenue (ttm) 27.17M
Net Income (ttm) -24.26M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -91.47%
Debt to Equity Ratio 0.00
Volume 84,534
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 26.52M
Stochastic %K 81%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. Its product includes aprevo, a medical platform that makes surgical plans and devices tailored to the precise medical situation of every individual patient. It provides New Technology Add-On Payment (NTAP) reimbursement. The company was incorporated in 2018 and is based in C...

Industry: Health Information Services
Sector: Healthcare
Phone: 760 766 1923
Address:
1800 Aston Avenue, Suite 100, Carlsbad, United States
JarvisFlow
JarvisFlow Aug. 18 at 2:34 PM
Truist Securities has adjusted their stance on Carlsmed ( $CARL ), setting the rating to Buy with a target price of 18.
0 · Reply
erevnon
erevnon Aug. 18 at 1:58 PM
Goldman Sachs initiates coverage on Carlsmed $CARL at Buy rating and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Aug. 18 at 11:30 AM
Goldman Sachs has updated their rating for Carlsmed ( $CARL ) to Buy with a price target of 19.
0 · Reply
JarvisFlow
JarvisFlow Aug. 18 at 11:00 AM
Piper Sandler has updated their rating for Carlsmed ( $CARL ) to Overweight with a price target of 18.
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 18 at 1:58 AM
Carlsmed Stock Down 6% Since IPO But Goldman Bullish And Predicts 35% Upside Potential — Retail Traders Stay Bearish $CARL https://stocktwits.com/news/equity/markets/carlsmed-stock-down-6-since-ipo-but-goldman-bullish-and-predicts-35-upside-potential-retail-traders-stay-bearish/chsauoBRdQd
0 · Reply
PurpleSquirrel2020
PurpleSquirrel2020 Aug. 7 at 5:54 PM
$CARL taking a starter in here. $15 ipo now $12.. AI next generation of spine surgery . Recommendations should be coming soon.. I’ll play
0 · Reply
KC112
KC112 Aug. 7 at 12:44 PM
0 · Reply
KC112
KC112 Aug. 7 at 12:44 PM
0 · Reply
JarvisFlow
JarvisFlow Aug. 18 at 2:34 PM
Truist Securities has adjusted their stance on Carlsmed ( $CARL ), setting the rating to Buy with a target price of 18.
0 · Reply
erevnon
erevnon Aug. 18 at 1:58 PM
Goldman Sachs initiates coverage on Carlsmed $CARL at Buy rating and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Aug. 18 at 11:30 AM
Goldman Sachs has updated their rating for Carlsmed ( $CARL ) to Buy with a price target of 19.
0 · Reply
JarvisFlow
JarvisFlow Aug. 18 at 11:00 AM
Piper Sandler has updated their rating for Carlsmed ( $CARL ) to Overweight with a price target of 18.
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 18 at 1:58 AM
Carlsmed Stock Down 6% Since IPO But Goldman Bullish And Predicts 35% Upside Potential — Retail Traders Stay Bearish $CARL https://stocktwits.com/news/equity/markets/carlsmed-stock-down-6-since-ipo-but-goldman-bullish-and-predicts-35-upside-potential-retail-traders-stay-bearish/chsauoBRdQd
0 · Reply
PurpleSquirrel2020
PurpleSquirrel2020 Aug. 7 at 5:54 PM
$CARL taking a starter in here. $15 ipo now $12.. AI next generation of spine surgery . Recommendations should be coming soon.. I’ll play
0 · Reply
KC112
KC112 Aug. 7 at 12:44 PM
0 · Reply
KC112
KC112 Aug. 7 at 12:44 PM
0 · Reply